Parametric Portfolio Associates’s SpringWorks Therapeutics SWTX Stock Holding History

Parametric Portfolio Associates’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$1.75M	Buy	31,048 +3,074	+11%	+$176K	﹤0.01%	2491
2021 Q4	$1.73M	Buy	27,974 +220	+0.8%	+$14.6K	﹤0.01%	2517
2021 Q3	$1.76M	Buy	27,754 +329	+1%	+$25.4K	﹤0.01%	2508
2021 Q2	$2.26M	Sell	27,425 -324	-1%	-$24.6K	﹤0.01%	2364
2021 Q1	$2.04M	Buy	27,749 +846	+3%	+$66.3K	﹤0.01%	2761
2020 Q4	$1.95M	Buy	26,903 +3,068	+13%	+$197K	﹤0.01%	2666
2020 Q3	$1.14M	Buy	23,835 +3,004	+14%	+$128K	﹤0.01%	2840
2020 Q2	$875K	Buy	20,831 +4,032	+24%	+$143K	﹤0.01%	2983
2020 Q1	$454K	Buy	16,799 +596	+4%	+$19.4K	﹤0.01%	3210
2019 Q4	$624K	Sell	16,203 -24,311	-60%	-$569K	﹤0.01%	3285
2019 Q3	$878K	Buy	+40,514	New	+$958K	﹤0.01%	3092

Other funds holding SWTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Parametric Portfolio Associates's SWTX Position: Q1 2022 in Review

Parametric Portfolio Associates increased its SpringWorks Therapeutics (SWTX) stake by 11% in Q1 2022, buying an estimated $176K and bringing the position to 31,048 shares worth $1.75M. The position accounts for ﹤0.01% of the portfolio, ranked #2491.

Parametric Portfolio Associates first reported a position in SWTX in Q3 2019 and has held it in 11 quarters since. The position peaked at $2.26M in Q2 2021. 137 funds tracked by Wall St. Rank hold SWTX as of Q1 2022.

Parametric Portfolio Associates held 31,048 shares of SpringWorks Therapeutics worth $1.75M as of Q1 2022.
Parametric Portfolio Associates bought 3,074 SpringWorks Therapeutics shares in Q1 2022, an estimated $176K.
SpringWorks Therapeutics made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2491 holding.
Parametric Portfolio Associates first reported a position in SpringWorks Therapeutics in Q3 2019 and has held it in 11 quarters since.
Parametric Portfolio Associates's SpringWorks Therapeutics position peaked at $2.26M in Q2 2021.
137 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.